Brought to you by:
The top 10 most popular Vascular Specialist stories of May 2023
Last month, Vascular Specialist most piqued reader interest with a commentary from the editor-in-chief on why he supports the decision by the Southern Association for Vascular Surgery (SAVS) to replace its emblem; a guest editorial examining whether physicians nowadays can experience both…
Adding 8–12mm diameter devices to the Shockwave Peripheral Intravascular Lithotripsy toolkit
This advertorial is sponsored by Shockwave Medical. Mazin Foteh, MD, contrasts the benefits of Shockwave Medical’s new Shockwave L6 Peripheral Intravascular Lithotripsy Catheter alongside those of its sister device, the Shockwave M5+ Peripheral Intravascular Lithotripsy Catheter. The Shockwave L6 device…
New ‘biopsychosocial’ roadmap set out to address PAD treatment and mental health impacts
A recent proposal has called for “whole-person, multidisciplinary interventions” after an interrogation of the interplay between lower extremity peripheral arterial disease (PAD) and mental health impacts. Published in the Journal of The American College of Cardiology, researchers have put forward…
Government Grand Rounds: Educating through advocacy
Since the initial launch of the Cancer Moonshot in 2016, the cancer community has made tangible progress towards ambitious goals, including accelerating scientific discovery in cancer, fostering greater collaboration and improving data-sharing. Just last year, U.S. President Joe Biden announced…
BASIL-2 points towards endovascular-first revascularization strategy in CLTI patients
A question from Manj Gohel, MD, from Cambridge University Hospitals in Cambridge, England, on what the 2023 Charing Cross (CX) International Symposium audience should take back to their multidisciplinary team meetings from the first-time presentation of BASIL-2 led chief investigator…
Surmodics announces successful first patient use of Sublime radial access microcatheter
Surmodics has announced that Ankur Lodha, MD, an interventional cardiologist at the Cardiovascular Institute of the South in Lafayette, Lousiana, and Pradeep Nair, director of the institute’s vein program, were the first physicians to use the company’s Sublime radial access…
The BeBack crossing catheter: A ‘game-changer’ in endovascular PAD practice
This advertorial is sponsored by Bentley. Crossing chronic total occlusion (CTO) lesions is a challenging procedure. The BeBack crossing catheter—Bentley’s first product to be available in both Europe and the United States following the company’s acquisition of Upstream Peripheral Medical…
SVS member named 2023 Presidential Leadership Scholar
Society for Vascular Surgery (SVS) member Anahita Dua, MD, has been named a Presidential Leadership Scholar for 2023. She is one of 60 scholars in this eighth annual class. Dua is an associate professor of surgery at Massachusetts General Hospital…
On 45th anniversary, CX Symposium chairman credits Chicago vascular surgical tandem for enduring success
The occasion of a seminal meeting held in Chicago by former Society for Vascular Surgery (SVS) Presidents John J. Bergan, MD, and James S.T. (Jimmy) Yao, MD, played a central role in the formation of the world-renowned Charing Cross (CX)…
SCVS 2023: DAPT shows higher survival rate in patients with low WIfI scores, study indicates
A retrospective cohort study presented at the 2023 Society for Clinical Vascular Surgery (SCVS) Annual Symposium in Miami (March 25–29) has found lower-extremity bypass patients who received dual antiplatelet therapy or anticoagulation (DAPT/AC) postoperatively had a higher 30-day survival rate.…